Tecan Group AG
Company Profile
Business description
Tecan Group AG sells automated laboratory instruments and solutions for the diagnostics and life sciences research markets. The firm operates in two segments; The Life Sciences Business (end-customer business) segment supplies end users with automated workflow solutions directly. These solutions include laboratory instruments, software packages, application know-how, services, consumables, and spare parts, The partnering Business (OEM business) segment develops and manufactures OEM instruments and components that are distributed by partner companies under their names. A majority proportion of Tecan's revenue is generated in the Americas and Europe.
Contact
Seestrasse 103
Mannedorf8708
CHET: +41 449228430
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
3,000
Stocks News & Analysis
stocks
Is this still an ASX share to own forever?
stocks
After earnings, is Nvidia stock a buy, a sell, or fairly valued?
stocks
Short-term pain for long-term gain for undervalued ASX share
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,010.10 | 117.10 | -1.28% |
CAC 40 | 7,719.71 | 65.46 | 0.86% |
DAX 40 | 23,594.80 | 107.47 | 0.46% |
Dow JONES (US) | 45,271.23 | 24.58 | -0.05% |
FTSE 100 | 9,177.99 | 61.30 | 0.67% |
HKSE | 25,343.43 | 153.12 | -0.60% |
NASDAQ | 21,497.73 | 218.10 | 1.02% |
Nikkei 225 | 41,938.89 | 371.60 | -0.88% |
NZX 50 Index | 13,074.81 | 58.35 | -0.44% |
S&P 500 | 6,448.26 | 32.72 | 0.51% |
S&P/ASX 200 | 8,738.80 | 120.20 | -1.36% |
SSE Composite Index | 3,813.56 | 44.58 | -1.16% |